Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 8, Issue 7, pp. 844-850
PubMed
Published By
Print ISSN
Online ISSN
History
- Received July 24, 2019
- Revision received November 1, 2019
- Accepted April 17, 2020
- Published first April 22, 2020.
Article Versions
- Previous version (April 22, 2020 - 05:51).
- Previous version (May 21, 2020 - 05:58).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Marie-Claire Wagle1,*,
- Joseph Castillo1,
- Shrividhya Srinivasan1,
- Thomas Holcomb1,
- Kobe C. Yuen1,
- Edward E. Kadel1,
- Sanjeev Mariathasan1,
- Daniel L. Halligan2,
- Adrian R. Carr2,
- Max Bylesjo2,
- Paul R. McAdam2,
- Sarah Lynagh2,
- Koen M. Marien3,
- Mark Kockx3,
- Yannick Waumans3,
- Shih-Min A. Huang1,
- Mark R. Lackner1, and
- Zineb Mounir1,*
- 1Oncology Biomarker Development, Genentech, Inc., South San Francisco, California.
- 2Fios Genomics, Nine Edinburgh Bioquarter, Edinburgh, United Kingdom.
- 3HistoGeneX, Antwerp, Belgium.
- ↵*Corresponding Authors:
Zineb Mounir, IDEAYA Biosciences, 7000 Shoreline Court, Suite 350, South San Francisco, CA 94080. Phone: 617-645-8009; E-mail: zineb.mounir{at}mail.mcgill.ca; and Marie-Claire Wagle, mariewagle{at}gmail.com
July 2020
Volume 8, Issue 7
Volume 8, Issue 7
Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate Cancer
Jump to section
Advertisement